Suchergebnisse - "TT6HN20MVF"

PubPharm (8)

1

Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience

enthalten in: BMC cancer | 2020

von Striefler, J. | Brandes, F. | Baur, A. | +9

2

A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Vornicova, O. | Haim, N. | Bar-Sela, G.

3

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts

enthalten in: BMC cancer | 2019

von Cornillie, J. | Wozniak, A. | Van Renterghem, B. | +7

4

Olaratumab in the management of advanced soft tissue sarcoma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2019

von Zobniw, C. | Trinh, V. | Posey, K. | +1

5

Olaratumab in soft tissue sarcoma - Current status and future perspectives

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Antoniou, G. | Lee, A. | Huang, P. | +1

CommentIn: Eur J Cancer. 2019 Aug;117:69-70. - PMID 31254941

6

EJC's biennial report on metastatic soft tissue sarcoma : State of the art and future perspectives

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Vos, M. | Sleijfer, S.

7

Olaratumab for the treatment of advanced soft tissue sarcoma

enthalten in: Expert review of anticancer therapy | 2017

von Okuno, S. | Maran, A. | Robinson, S.

8

Olaratumab for the treatment of soft tissue sarcoma

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2017

von Deshpande, H. | Cecchini, M. | Ni Choileain, S. | +1

1
[1]